Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections

Sang Jun Ha, Erin E. West, Koichi Araki, Kendall A. Smith, Rafi Ahmed

Research output: Contribution to journalReview article

65 Citations (Scopus)

Abstract

One potentially promising strategy to control chronic infections such as human immunodeficiency virus, hepatitis B virus, and hepatitis C virus is therapeutic vaccination, which aims to reduce persisting virus by stimulating a patient's own antiviral immune responses. However, this approach has fallen short of expectations, because antiviral T cells generated during chronic infections often become functionally exhausted and thus do not respond properly to therapeutic vaccination. Therefore, it is necessary to develop a therapeutic vaccine strategy to more effectively boost endogenous T-cell responses to control persistent viral infections. Studies to elucidate the cause of impaired T-cell function have pointed to sustained inhibitory receptor signaling through T-cell expression of programmed death 1 (PD-1). Recently, another inhibitory molecule, cytotoxic T lymphocyte antigen 4 (CTLA-4), and also an immunosuppressive cytokine, interleukin 10 (IL-10), have been reported to be potential factors of establishing immune suppression and viral persistence. Blocking these negative signaling pathways could restore the host immune system, enabling it to respond to further stimulation. Indeed, combining therapeutic vaccination along with the blockade of inhibitory signals could synergistically enhance functional CD8+ T-cell responses and improve viral control in chronically infected mice, providing a promising strategy for the treatment of chronic viral infections. Furthermore, not only the ablation of negative signals but also the addition of stimulatory signals, such as interleukin 2 (IL-2), might prove to be a potentially promising strategy to augment the efficacy of therapeutic vaccination against chronic viral infections.

Original languageEnglish
Pages (from-to)317-333
Number of pages17
JournalImmunological Reviews
Volume223
Issue number1
DOIs
Publication statusPublished - 2008 Jun 1

Fingerprint

Virus Diseases
Immune System
Vaccination
T-Lymphocytes
Antiviral Agents
Therapeutics
CTLA-4 Antigen
Immunologic Factors
Immunosuppressive Agents
Infection Control
Hepatitis B virus
Hepacivirus
Interleukin-10
Interleukin-2
Vaccines
HIV
Cytokines
Viruses
Infection

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

@article{be5d51cf4a574334b9724f58404dcd78,
title = "Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections",
abstract = "One potentially promising strategy to control chronic infections such as human immunodeficiency virus, hepatitis B virus, and hepatitis C virus is therapeutic vaccination, which aims to reduce persisting virus by stimulating a patient's own antiviral immune responses. However, this approach has fallen short of expectations, because antiviral T cells generated during chronic infections often become functionally exhausted and thus do not respond properly to therapeutic vaccination. Therefore, it is necessary to develop a therapeutic vaccine strategy to more effectively boost endogenous T-cell responses to control persistent viral infections. Studies to elucidate the cause of impaired T-cell function have pointed to sustained inhibitory receptor signaling through T-cell expression of programmed death 1 (PD-1). Recently, another inhibitory molecule, cytotoxic T lymphocyte antigen 4 (CTLA-4), and also an immunosuppressive cytokine, interleukin 10 (IL-10), have been reported to be potential factors of establishing immune suppression and viral persistence. Blocking these negative signaling pathways could restore the host immune system, enabling it to respond to further stimulation. Indeed, combining therapeutic vaccination along with the blockade of inhibitory signals could synergistically enhance functional CD8+ T-cell responses and improve viral control in chronically infected mice, providing a promising strategy for the treatment of chronic viral infections. Furthermore, not only the ablation of negative signals but also the addition of stimulatory signals, such as interleukin 2 (IL-2), might prove to be a potentially promising strategy to augment the efficacy of therapeutic vaccination against chronic viral infections.",
author = "Ha, {Sang Jun} and West, {Erin E.} and Koichi Araki and Smith, {Kendall A.} and Rafi Ahmed",
year = "2008",
month = "6",
day = "1",
doi = "10.1111/j.1600-065X.2008.00638.x",
language = "English",
volume = "223",
pages = "317--333",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",
number = "1",

}

Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. / Ha, Sang Jun; West, Erin E.; Araki, Koichi; Smith, Kendall A.; Ahmed, Rafi.

In: Immunological Reviews, Vol. 223, No. 1, 01.06.2008, p. 317-333.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections

AU - Ha, Sang Jun

AU - West, Erin E.

AU - Araki, Koichi

AU - Smith, Kendall A.

AU - Ahmed, Rafi

PY - 2008/6/1

Y1 - 2008/6/1

N2 - One potentially promising strategy to control chronic infections such as human immunodeficiency virus, hepatitis B virus, and hepatitis C virus is therapeutic vaccination, which aims to reduce persisting virus by stimulating a patient's own antiviral immune responses. However, this approach has fallen short of expectations, because antiviral T cells generated during chronic infections often become functionally exhausted and thus do not respond properly to therapeutic vaccination. Therefore, it is necessary to develop a therapeutic vaccine strategy to more effectively boost endogenous T-cell responses to control persistent viral infections. Studies to elucidate the cause of impaired T-cell function have pointed to sustained inhibitory receptor signaling through T-cell expression of programmed death 1 (PD-1). Recently, another inhibitory molecule, cytotoxic T lymphocyte antigen 4 (CTLA-4), and also an immunosuppressive cytokine, interleukin 10 (IL-10), have been reported to be potential factors of establishing immune suppression and viral persistence. Blocking these negative signaling pathways could restore the host immune system, enabling it to respond to further stimulation. Indeed, combining therapeutic vaccination along with the blockade of inhibitory signals could synergistically enhance functional CD8+ T-cell responses and improve viral control in chronically infected mice, providing a promising strategy for the treatment of chronic viral infections. Furthermore, not only the ablation of negative signals but also the addition of stimulatory signals, such as interleukin 2 (IL-2), might prove to be a potentially promising strategy to augment the efficacy of therapeutic vaccination against chronic viral infections.

AB - One potentially promising strategy to control chronic infections such as human immunodeficiency virus, hepatitis B virus, and hepatitis C virus is therapeutic vaccination, which aims to reduce persisting virus by stimulating a patient's own antiviral immune responses. However, this approach has fallen short of expectations, because antiviral T cells generated during chronic infections often become functionally exhausted and thus do not respond properly to therapeutic vaccination. Therefore, it is necessary to develop a therapeutic vaccine strategy to more effectively boost endogenous T-cell responses to control persistent viral infections. Studies to elucidate the cause of impaired T-cell function have pointed to sustained inhibitory receptor signaling through T-cell expression of programmed death 1 (PD-1). Recently, another inhibitory molecule, cytotoxic T lymphocyte antigen 4 (CTLA-4), and also an immunosuppressive cytokine, interleukin 10 (IL-10), have been reported to be potential factors of establishing immune suppression and viral persistence. Blocking these negative signaling pathways could restore the host immune system, enabling it to respond to further stimulation. Indeed, combining therapeutic vaccination along with the blockade of inhibitory signals could synergistically enhance functional CD8+ T-cell responses and improve viral control in chronically infected mice, providing a promising strategy for the treatment of chronic viral infections. Furthermore, not only the ablation of negative signals but also the addition of stimulatory signals, such as interleukin 2 (IL-2), might prove to be a potentially promising strategy to augment the efficacy of therapeutic vaccination against chronic viral infections.

UR - http://www.scopus.com/inward/record.url?scp=47249098958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249098958&partnerID=8YFLogxK

U2 - 10.1111/j.1600-065X.2008.00638.x

DO - 10.1111/j.1600-065X.2008.00638.x

M3 - Review article

C2 - 18613845

AN - SCOPUS:47249098958

VL - 223

SP - 317

EP - 333

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

IS - 1

ER -